论文部分内容阅读
为了研究健延龄（含首乌、黄芪、西洋参等数种有效降脂中药）的调脂作用，将１２８例高脂血症患者分成治疗组及对照组进行随机双盲观察，３个月后健延龄组胆固醇（ＴＣ）、甘油三酯（ＴＧ）、胆固醇／高密度脂蛋白胆固醇（ＴＣ／ＨＤＬ－Ｃ）、载脂蛋白Ｂ（ＡｐｏＢ）、ＡｐｏＡ／ＡｐｏＢ、脂蛋白（ａ）〔Ｌｐ（ａ）〕与治疗前及与对照组比较，Ｐ均＜０．０１，认为该药有较好的调脂作用，有抗动脉粥样硬化作用，是值得推广应用的新药。
In order to study the lipid-regulating effects of Jianyanling (including several effective lipid-lowering herbs such as Shouwu, Huangqi, and American ginseng), 128 patients with hyperlipidemia were divided into treatment and control groups for randomized double-blind observation. After 3 months, Jianyanling group cholesterol (TC), triglyceride (TG), cholesterol/high-density lipoprotein cholesterol (TC/HDL-C), apolipoprotein B (ApoB), ApoA/ApoB, lipoprotein (a) [Lp (a)] Before treatment and compared with the control group, P <0.01, it is considered that the drug has a good lipid-regulating effect, anti-atherosclerosis effect, it is worthy of promotion and application of new drugs.